Special Issue: Cyclodextrin-Based Approach in Biotechnology
A special issue on cyclodextrin based approach in biotechnology to be published in Future Pharmacology (an international, scientific, peer-reviewed, open
A forum for researchers, students and applicants in the field of cyclodextrin technology
A special issue on cyclodextrin based approach in biotechnology to be published in Future Pharmacology (an international, scientific, peer-reviewed, open
In recent years, liquid biopsy has garnered considerable attention as a valuable diagnostic technology for cancer. An analysis target of
Ligand Pharmaceuticals Incorporated presented positive results from a Phase 1 clinical trial of its Captisol-enabled (CE) Iohexol program at ASN
Field: AI and Robot / Composite Materials / IT and ICT / Energy Materials / Biomaterials / Photonic, Electronic and
Ligand Pharmaceuticals Incorporated announced completion of enrollment of the Company’s Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol
The application of cyclodextrins as excipients is wellspread, common knowledge worldwide. Their application as APIs is getting huge publicity, developments